Treatment of the non neurogenic overactive bladder with botuline toxin a detrusorinjections

Author： Marchand W. Merckx L. Maes D. Gillis J. Everaert K. De Ridder D.

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 220-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Women’s perspective of botulinum toxin treatment for overactive bladder symptoms

By Digesu G. Panayi Demetri Hendricken Caroline Camarata Michelle Fernando Ruwan Khullar Vikram

International Urogynecology Journal, Vol. 22, Iss. 4, 2011-04 ,pp. : 425-431

Springer Publishing Company

Access to resources Recommend Favorite

Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder

By Schulte-Baukloh H. Michael T. Sturzebecher B. Knispel H.H.

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 139-143

Elsevier

Access to resources Recommend Favorite

Tolterodine once-daily in treatment of the overactive bladder

By Peters K.M. Huang R.R.

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 829-829

Elsevier

Access to resources Recommend Favorite

Successful treatment of overactive bladder in a child with myasthenia gravis

By Pannek Jurgen Grigoleit Ute

Scandinavian Journal of Urology and Nephrology, Vol. 42, Iss. 4, 2008-01 ,pp. : 397-398

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine treatment augmented by simplified bladder training in Overactive Bladder (OAB) patients

By Mattiason A. Massey D.

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 133-133

Elsevier

Access to resources Recommend Favorite